Literature DB >> 19926414

Identification and quantitation of 3,4-methylenedioxy-N-methylamphetamine (MDMA, ecstasy) in human urine by 1H NMR spectroscopy. Application to five cases of intoxication.

Jonathan Liu1, John Decatur, Gloria Proni, Elise Champeil.   

Abstract

Identification of 3,4-methylenedioxy-N-methylamphetamine (MDMA, ecstasy) in five cases of intoxication using nuclear magnetic resonance (NMR) spectroscopy of human urine is reported. A new water suppression technique PURGE (Presaturation Utilizing Relaxation Gradients and Echoes) was used. A calibration curve was obtained using spiked samples. The method gave a linear response (correlation coefficient of 0.992) over the range 0.01-1mg/mL. Subsequently, quantitation of the amount of MDMA present in the samples was performed. The benefit and reliability of NMR investigations of human urine for cases of intoxication with MDMA are discussed. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19926414     DOI: 10.1016/j.forsciint.2009.10.022

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  3 in total

Review 1.  1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?

Authors:  Sylvana Vilca-Melendez; Malin V Uthaug; Julian L Griffin
Journal:  Front Psychiatry       Date:  2021-12-13       Impact factor: 4.157

2.  A High-Resolution Magic Angle Spinning NMR Study of the Enantiodiscrimination of 3,4-Methylenedioxymethamphetamine (MDMA) by an Immobilized Polysaccharide-Based Chiral Phase.

Authors:  Juliana C Barreiro; Márcio W Paixão; Tiago C Lourenço; Quezia B Cass; Tiago Venâncio
Journal:  PLoS One       Date:  2016-09-26       Impact factor: 3.240

Review 3.  Forensic NMR metabolomics: one more arrow in the quiver.

Authors:  Emanuela Locci; Giovanni Bazzano; Alberto Chighine; Francesco Locco; Ernesto Ferraro; Roberto Demontis; Ernesto d'Aloja
Journal:  Metabolomics       Date:  2020-11-07       Impact factor: 4.290

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.